Kimberly Blackwell
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer (NCT02598427) | Kimberly Blackwell | 2017-05-01 |
Track Kimberly Blackwell automatically
Every clearance here is in the API, with alerts when new ones post.